Lysophosphatidic acid induces increased BACE1 expression and Aβ formation

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1832, Issue 1, 2013, Pages 29-38

  Shi, Jing ^a   Dong, Yunzhou ^a,b   Cui, Mei Zhen ^a   Xu, Xuemin ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

Secretase; Alzheimer's disease; Amyloid precursor protein; Beta amyloid peptide; Lysophosphatidic acid; Oxidized LDL

Indexed keywords

AMYLOID BETA PROTEIN; BETA SECRETASE; BETA SECRETASE 1; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GAMMA SECRETASE; LYSOPHOSPHATIDIC ACID; OXIDIZED LOW DENSITY LIPOPROTEIN; PROTEIN KINASE C; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR SP1;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CARDIOVASCULAR RISK; CELL CULTURE; CONTROLLED STUDY; GENE EXPRESSION; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; WESTERN BLOTTING;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; ASPARTIC ACID ENDOPEPTIDASES; CELL LINE, TUMOR; HUMANS; LIPOPROTEINS, LDL; LYSOPHOSPHOLIPIDS; MICE; UP-REGULATION;

EID: 84868534995     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2012.09.010     Document Type: Article

References (49)

1. Walsh D.M., Klyubin I., Fadeeva J.V., Rowan M.J., Selkoe D.J. Amyloid-beta oligomers: their production, toxicity and therapeutic inhibition. Biochem. Soc. Trans. 2002, 30:552-557.
2. Selkoe D.J. Alzheimer's disease is a synaptic failure. Science 2002, 298:789-791.
3. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297:353-356.
4. Selkoe D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 2001, 81:741-766.
5. Yan R., Bienkowski M.J., Shuck M.E., Miao H., Tory M.C., Pauley A.M., Brashier J.R., Stratman N.C., Mathews W.R., Buhl A.E., Carter D.B., Tomasselli A.G., Parodi L.A., Heinrikson R.L., Gurney M.E. Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. Nature 1999, 402:533-537.
6. Vassar R., Bennett B.D., Babu-Khan S., Kahn S., Mendiaz E.A., Denis P., Teplow D.B., Ross S., Amarante P., Loeloff R., Luo Y., Fisher S., Fuller J., Edenson S., Lile J., Jarosinski M.A., Biere A.L., Curran E., Burgess T., Louis J.C., Collins F., Treanor J., Rogers G., Citron M. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 1999, 286:735-741.
7. Hussain I., Powell D., Howlett D.R., Tew D.G., Meek T.D., Chapman C., Gloger I.S., Murphy K.E., Southan C.D., Ryan D.M., Smith T.S., Simmons D.L., Walsh F.S., Dingwall C., Christie G. Identification of a novel aspartic protease (Asp 2) as beta-secretase. Mol. Cell. Neurosci. 1999, 14:419-427.
8. Sinha S., Anderson J.P., Barbour R., Basi G.S., Caccavello R., Davis D., Doan M., Dovey H.F., Frigon N., Hong J., Jacobson-Croak K., Jewett N., Keim P., Knops J., Lieberburg I., Power M., Tan H., Tatsuno G., Tung J., Schenk D., Seubert P., Suomensaari S.M., Wang S., Walker D., Zhao J., McConlogue L., John V. Purification and cloning of amyloid precursor protein beta-secretase from human brain. Nature 1999, 402:537-540.
9. Xu X. γ-Secretase catalyzes sequential cleavages of the AβPP transmembrane domain. J. Alzheimers Dis. 2009, 16:211-224.
10. Casado A., Encarnacion Lopez-Fernandez M., Concepcion Casado M., de La Torre R. Lipid peroxidation and antioxidant enzyme activities in vascular and Alzheimer dementias. Neurochem. Res. 2008, 33:450-458.
11. Cacabelos R., Fernandez-Novoa L., Lombardi V., Corzo L., Pichel V., Kubota Y. Cerebrovascular risk factors in Alzheimer's disease: brain hemodynamics and pharmacogenomic implications. Neurol. Res. 2003, 25:567-580.
12. Panza F., D'Introno A., Colacicco A.M., Basile A.M., Capurso C., Kehoe P.G., Capurso A., Solfrizzi V. Vascular risk and genetics of sporadic late-onset Alzheimer's disease. J. Neural Transm. 2004, 111:69-89.
13. Draczynska-Lusiak B., Doung A., Sun A.Y. Oxidized lipoproteins may play a role in neuronal cell death in Alzheimer disease. Mol. Chem. Neuropathol. 1998, 33:139-148.
14. Giasson B.I., Ischiropoulos H., Lee V.M., Trojanowski J.Q. The relationship between oxidative/nitrative stress and pathological inclusions in Alzheimer's and Parkinson's diseases. Free Radic. Biol. Med. 2002, 32:1264-1275.
15. Bassett C.N., Neely M.D., Sidell K.R., Markesbery W.R., Swift L.L., Montine T.J. Cerebrospinal fluid lipoproteins are more vulnerable to oxidation in Alzheimer's disease and are neurotoxic when oxidized ex vivo. Lipids 1999, 34:1273-1280.
16. Sun Y.X., Minthon L., Wallmark A., Warkentin S., Blennow K., Janciauskiene S. Inflammatory markers in matched plasma and cerebrospinal fluid from patients with Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 2003, 16:136-144.
17. Frisardi V., Panza F., Seripa D., Farooqui T., Farooqui A.A. Glycerophospholipids and glycerophospholipid-derived lipid mediators: a complex meshwork in Alzheimer's disease pathology. Prog. Lipid Res. 2011, 50:313-330.
18. Parola M., Bellomo G., Robino G., Barrera G., Dianzani M.U. 4-Hydroxynonenal as a biological signal: molecular basis and pathophysiological implications. Antioxid. Redox Signal. 1999, 1:255-284.
19. Cui M.Z., Zhao G., Winokur A.L., Laag E., Bydash J.R., Penn M.S., Chisolm G.M., Xu X. Lysophosphatidic acid induction of tissue factor expression in aortic smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 2003, 23:224-230.
20. Ge Y.W., Maloney B., Sambamurti K., Lahiri D.K. Functional characterization of the 5' flanking region of the BACE gene: identification of a 91 bp fragment involved in basal level of BACE promoter expression. FASEB J. 2004, 18:1037-1039.
21. Zhao G., Mao G., Tan J., Dong Y., Cui M.-Z., Kim S.-H., Xu X. Identification of a new presenilin-dependent ζ-cleavage site within the transmembrane domain of amyloid precursor protein. J. Biol. Chem. 2004, 279:50647-50650.
22. Zhao G., Cui M.Z., Mao G., Dong Y., Tan J., Sun L., Xu X. γ-Cleavage is dependent on ζ-cleavage during the proteolytic processing of amyloid precursor protein within its transmembrane domain. J. Biol. Chem. 2005, 280:37689-37697.
23. Kim S.H., Leem J.Y., Lah J.J., Slunt H.H., Levey A.I., Thinakaran G., Sisodia S.S. Multiple effects of aspartate mutant presenilin 1 on the processing and trafficking of amyloid precursor protein. J. Biol. Chem. 2001, 276:43343-43350.
24. Cui M.Z., Laag E., Sun L., Tan M., Zhao G., Xu X. Lysophosphatidic acid induces early growth response gene 1 expression in vascular smooth muscle cells: CRE and SRE mediate the transcription. Arterioscler. Thromb. Vasc. Biol. 2006, 26:1029-1035.
25. Tan J., Mao G., Cui M.Z., Kang S.C., Lamb B., Wong B.S., Sy M.S., Xu X. Effects of gamma-secretase cleavage-region mutations on APP processing and Abeta formation: interpretation with sequential cleavage and alpha-helical model. J. Neurochem. 2008, 107:722-733.
26. Kim K.S., Wen G.Y., Bancher C., Chen C.M.J., Sapienza V.J., Hong H., Wisniewski H.M. Detection and quantitation of amyloid B-peptide with 2 monoclonal antibodies. Neurosci. Res. Commun. 1990, 7:113-122.
27. Christensen M.A., Zhou W., Qing H., Lehman A., Philipsen S., Song W. Transcriptional regulation of BACE1, the beta-amyloid precursor protein beta-secretase, by Sp1. Mol. Cell. Biol. 2004, 24:865-874.
28. Cui M.Z., Penn M.S., Chisolm G.M. Native and oxidized low density lipoprotein induction of tissue factor gene expression in smooth muscle cells is mediated by both Egr-1 and Sp1. J. Biol. Chem. 1999, 274:32795-32802.
29. Cui M.Z. Lysophosphatidic acid effects on atherosclerosis and thrombosis. Clin. Lipidol. 2011, 6:413-426.
30. Chyan Y.-J., Rawson T.Y., Wilson S.H. Cloning and characterization of a novel member of the human ATF/CREB family: ATF2 deletion, a potential regulator of the human DNA polymerase [beta] promoter. Gene 2003, 312:117-124.
31. Blois J.T., Mataraza J.M., Mecklenbrauker I., Tarakhovsky A., Chiles T.C. B cell receptor-induced cAMP-response element-binding protein activation in B lymphocytes requires novel protein kinase Cdelta. J. Biol. Chem. 2004, 279:30123-30132.
32. Takahashi T., Kawahara Y., Okuda M., Ueno H., Takeshita A., Yokoyama M. Angiotensin II stimulates mitogen-activated protein kinases and protein synthesis by a Ras-independent pathway in vascular smooth muscle cells. J. Biol. Chem. 1997, 272:16018-16022.
33. Hedges J.C., Dechert M.A., Yamboliev I.A., Martin J.L., Hickey E., Weber L.A., Gerthoffer W.T. A role for p38(MAPK)/HSP27 pathway in smooth muscle cell migration. J. Biol. Chem. 1999, 274:24211-24219.
34. Miano J.M., Carlson M.J., Spencer J.A., Misra R.P. Serum response factor-dependent regulation of the smooth muscle calponin gene. J. Biol. Chem. 2000, 275:9814-9822.
35. Tan M., Xu X., Ohba M., Ogawa W., Cui M.Z. Thrombin rapidly induces protein kinase D phosphorylation, and protein kinase C delta mediates the activation. J. Biol. Chem. 2003, 278:2824-2828.
36. Siess W., Zangl K.J., Essler M., Bauer M., Brandl R., Corrinth C., Bittman R., Tigyi G., Aepfelbacher M. Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:6931-6936.
37. Pagès C., Simon M.-F., Valet P., Saulnier-Blache J.S. Lysophosphatidic acid synthesis and release. Prostaglandins Other Lipid Mediat. 2001, 64:1-10.
38. Umemura K., Yamashita N., Yu X., Arima K., Asada T., Makifuchi T., Murayama S., Saito Y., Kanamaru K., Goto Y., Kohsaka S., Kanazawa I., Kimura H. Autotaxin expression is enhanced in frontal cortex of Alzheimer-type dementia patients. Neurosci. Lett. 2006, 400:97-100.
39. Tamagno E., Bardini P., Obbili A., Vitali A., Borghi R., Zaccheo D., Pronzato M.A., Danni O., Smith M.A., Perry G., Tabaton M. Oxidative stress increases expression and activity of BACE in NT2 neurons. Neurobiol. Dis. 2002, 10:279-288.
40. Xiong K., Cai H., Luo X.G., Struble R.G., Clough R.W., Yan X.X. Mitochondrial respiratory inhibition and oxidative stress elevate beta-secretase (BACE1) proteins and activity in vivo in the rat retina. Exp. Brain Res. 2007, 181:435-446.
41. Buxbaum J.D., Oishi M., Chen H.I., Pinkas-Kramarski R., Jaffe E.A., Gandy S.E., Greengard P. Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:10075-10078.
42. Nitsch R.M., Slack B.E., Wurtman R.J., Growdon J.H. Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science 1992, 258:304-307.
43. Wolf B.A., Wertkin A.M., Jolly Y.C., Yasuda R.P., Wolfe B.B., Konrad R.J., Manning D., Ravi S., Williamson J.R., Lee V.M. Muscarinic regulation of Alzheimer's disease amyloid precursor protein secretion and amyloid beta-protein production in human neuronal NT2N cells. J. Biol. Chem. 1995, 270:4916-4922.
44. Lee R.K., Wurtman R.J., Cox A.J., Nitsch R.M. Amyloid precursor protein processing is stimulated by metabotropic glutamate receptors. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:8083-8087.
45. Jolly-Tornetta C., Wolf B.A. Regulation of amyloid precursor protein (APP) secretion by protein kinase calpha in human ntera 2 neurons (NT2N). Biochemistry (Mosc) 2000, 39:7428-7435.
46. Yeon S.W., Jung M.W., Ha M.J., Kim S.U., Huh K., Savage M.J., Masliah E., Mook-Jung I. Blockade of PKC epsilon activation attenuates phorbol ester-induced increase of alpha-secretase-derived secreted form of amyloid precursor protein. Biochem. Biophys. Res. Commun. 2001, 280:782-787.
47. Zhu G., Wang D., Lin Y.H., McMahon T., Koo E.H., Messing R.O. Protein kinase C epsilon suppresses Abeta production and promotes activation of alpha-secretase. Biochem. Biophys. Res. Commun. 2001, 285:997-1006.
48. Rossner S., Mendla K., Schliebs R., Bigl V. Protein kinase Calpha and beta1 isoforms are regulators of alpha-secretory proteolytic processing of amyloid precursor protein in vivo. Eur. J. Neurosci. 2001, 13:1644-1648.
49. Kinouchi T., Sorimachi H., Maruyama K., Mizuno K., Ohno S., Ishiura S., Suzuki K. Conventional protein kinase C (PKC)-alpha and novel PKC epsilon, but not -delta, increase the secretion of an N-terminal fragment of Alzheimer's disease amyloid precursor protein from PKC cDNA transfected 3Y1 fibroblasts. FEBS Lett. 1995, 364:203-206.